CDER Small Business and Industry Assistance (SBIA)
Survey questions:
General Conference Questions:
Were you satisfied with the following aspects of the conference? Select all that apply:
Audio-visual
Conference Facilities
Conference Organization
Interaction with FDA Speakers
Food Services
Networking among Attendees
Registration Process
Room Temperature
How did you learn about this event?
Attended previously
FDA Email
Non-FDA Email
FDA Webpage
Non-FDA Webpage
Social media (e.g., Twitter)
Word of mouth
Would you recommend this event to a friend/colleague?
Yes
No
Not Sure
Did the event meet your objectives?
Yes
No
Partially
If both webcast and in-person conference are available, would you attend the conference in person or webcast?
Webcast
In Person
No Preference
For hybrid conferences (in person and online)
How did you attend the event?
I attended in-person in Silver Spring.
I attended virtually online.
If you attended virtually online:
What device did you use to attend the event?
An iPad
A tablet (other than iPad)
An iPhone
A smartphone (other than iPhone)
Other
Did you encounter any technical difficulties?
No
Yes - but they were minor and did not limit my participation
Yes - they greatly limited my ability to participate
If you answered yes above, please describe the difficulties.
[open text answer - optional]
Based on your experience, how likely are you to recommend virtual event attendance to your colleagues?
Unlikely
Neither Likely or Unlikely
Likely
Do you have any suggestions for improving future virtual events?
[open text answer – optional]
Session Questions:
Was this session valuable to you?
Yes
No
If you chose “yes” to the above question why did you rate the session as valuable (choose all that apply):
Topic was relevant to what I do
I learned something new and important about this topic
This information will be helpful to my colleagues
Will have a positive impact on what I do
Please rate the following statements about the speaker [agree; disagree; neutral]
Speaker adequately covered the subject
Speaker was knowledgeable of subject matter
Speaker answered questions clearly
Speaker adequately facilitated the session
Registration Questions:
Register using Email
Email Address *
First Name *
Last Name *
Password *
Verify Password *
How Will You Attend? *
a. Virtually online
b. In-Person Onsite
Company/Organization Name *
Type of Business? *
a. Manufacturer/Distributor
b. Research/Academia
c. Consultant
d. Regulatory
e. Other
Type of Business: Other (Specify)
Company/Organization Size* *
a. 1-9
b. 10-49
c. 50-99
d. 100-499
e. 500+
Job Category *
Executive
Director
Employee(staff)
Job Title *
City *
State *
State drop down list
Country *
Country
drop down list
Have you or your company submitted an NDA to FDA? *
Yes
We are in the process
No
Not sure
Have you or your company submitted a BLA to FDA? *
Yes
We are in the process
No
Not sure
Have you or your company submitted an ANDA to FDA? *
Yes
We are in the process
No
Not
sure
Would you like your name to appear in a participant list? *
Yes
No
Would you like your email address added to the SBIA Listserv? *
Yes
No
Do you have any questions on GDUFA relevant to the Agenda?
Please enter any future topics you would like us to cover:
Have you used the CDER SBIA web page (www.fda.gov/cdersbia)? Yes/No
If so, are you usually able to find what you are looking for on the webpage? Yes/No
If not, please indicate what you were looking for__________________
How can we improve the CDER SBIA webpage?___________________
At this REdI conference would you be available and willing to participate in an in-person, two-hour focus group?
Yes
No
**The CDER SBIA focus group will take place from 5-7 PM on the first afternoon of the Conference. Individual and company names of those selected for the focus group will be kept confidential. CDER SBIA will select participants from among those who indicate they are available and willing to participate in a focus group at the Conference.”
File Type | application/msword |
Author | Stodart, Brenda L |
Last Modified By | Mizrachi, Ila |
File Modified | 2015-07-21 |
File Created | 2015-07-20 |